MCC has launched a podcast – Clinical Trial Optimization (CTO). We'll be discussing the major issues affecting you, from Quality-by-Design, to risk based quality management and vendor oversight.
The first 6 episodes are scheduled and will be coming to you starting July 10th.
Episode 1: A discussion with Ken Getz
Episode 2: A discussion with Laurie Halloran
Episode 3: A discussion with Steve Young
Episode 4: A discussion with Duncan Hall
Episode 5: A discussion with Johann Proeve
Episode 6: A discussion with Nat KatzSign up to be notified when the first episode of CTO is released.
And you'll be able to listen to it on your favorite podcast player whether that be iTunes, Google Play, Stitcher, Pandora or Spotify
Leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement. Founded in 2006, MCC is the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers and sites to improve clinical-trial development through use of MCC standardized performance metrics.